Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.277
Delayed Data
As of Jun 22
 +0.002 / +0.73%
Today’s Change
0.16
Today|||52-Week Range
0.40
+17.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues88.0K148.0K32.0K132.0K
 
 
 
 
 
Depreciation And Amortization44.0K41.0K298.0K365.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.7M14.2M17.7M8.6M
 
 
 
 
 
Research And Development5.5M9.7M13.3M4.7M
 
 
 
 
 
Total Operating Expenses10.8M14.3M18.0M8.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-14.1M-18.0M-8.8M
 
 
 
 
 
Extraordinary Credit6.5M0.000.00215.0K
 
 
 
Extraordinary Charge-7.0M-9.2M-7.6M-11.5M
 
 
 
 
 
Interest Expense On Debt1.3M1.2M1.9M3.3M
 
 
 
 
 
Other Expenses2.3M1.3M420.0K1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.3M-23.3M-27.0M-21.5M
 
 
 
 
 
Preferred Dividend0.000.00-1.3M-10.1M
 
 
 
Net Income-10.3M-23.3M-27.0M-21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS208.5M281.5M328.9M356.2M
 
 
 
 
 
Shares To Calculate EPS Diluted208.5M281.5M328.9M356.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.08-$0.10-$0.09
 
 
 
 
 
EPS Diluted-$0.05-$0.08-$0.09-$0.09